$ Value
$0
Shares
1,669
Price
$0
Filed
Oct 15
Insider
Name
Pelish Henry E.
Title
Chief Scientific Officer
CIK
0002029477
Roles
Transaction Details
Transaction Date
2025-10-13
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
14,968
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2024. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.80 to $89.83, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.64 to $85.63, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.89 to $86.81, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.33 to $87.56, inclusive. | The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. | The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. | The shares underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. | The shares underlying this option have vested or shall vest over the four years following March 1, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Filing Info
Pelish Henry E.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-09 | NUVL | M | $86K |
| 2026-04-09 | NUVL | ▼ | $229K |
| 2026-04-09 | NUVL | ▼ | $94K |
| 2026-04-09 | NUVL | M | $0 |
| 2025-10-15 | NUVL | M | $69K |
| 2025-10-15 | NUVL | M | $209K |
| 2025-10-15 | NUVL | M | $220K |
| 2025-10-15 | NUVL | ▼ | $1.3M |
| 2025-10-15 | NUVL | M | $0 |
| 2025-10-15 | NUVL | M | $0 |
Other Insiders at NUVL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Balcom Alexandra
Chief Financial Officer
|
— | $3.7M | 2026-04-01 |
|
Noci Darlene
Chief Development Officer
|
— | $538K | 2026-03-30 |
|
Porter James Richard
President and CEO
|
— | $3.1M | 2026-04-06 |
|
Miller Deborah Ann
Chief Legal Officer
|
— | $543K | 2026-03-26 |
|
Pelish Henry E.
Chief Scientific Officer
|
— | $323K | 2026-04-09 |
|
Lane Benjamin
See Remarks
|
— | — | 2026-04-01 |